| abstract |
A method for treating diabetic retinopathy is provided. A method for treating diabetic retinopathy, comprising administering an effective amount of a therapeutic agent that inhibits the interaction between lymphocyte function-related antigen-1 (LFA-1) and intracellular adhesion molecule-1 (ICAM-1). . In the method of treatment, it is preferred to administer an effective amount of an LFA antagonist. The LFA antagonist is preferably a compound represented by the following formula. [Selection figure] None |